Oncotelic Therapeutics Inc.

04/29/2024 | Press release | Distributed by Public on 04/29/2024 05:19

Oncotelic Therapeutics, Inc. to Sell Its Necroptosis Cancer Therapy Assets to Mosaic ImmunoEngineering, Inc.